Treatment Algorithm for Osteonecrosis

Archival Presentation Notice: This article modernizes the multimedia presentation “Treatment Algorithm for Osteonecrosis of the Hip” originally presented by Michael A. Mont, M.D., Mike S. McGrath, M.D., and Michael G. Zywiel, M.D. (Rubin Institute for Advanced Orthopedics, Baltimore, Maryland). The historical Flash lecture has been reconstructed into the synchronized video slide presentation above, with the original file preserved in the digital archives (treatment_algorithm_for_osteonecrosis-mont.swf).

1. High-Yield Summary

Osteonecrosis of the femoral head (ONFH), also termed avascular necrosis (AVN), is a progressive, debilitating disease that primarily afflicts active individuals between the third and fifth decades of life. The condition is characterized by microvascular disruption, osteocyte death, and defective bone remodeling, which precipitate structural failure and articular collapse if untreated.

• The Pre-Collapse Opportunity Window: Joint-preserving interventions are strictly indicated before mechanical subchondral collapse occurs (Steinberg Stage I and II, ARCO Stage I and II). Once subchondral fracture (the crescent sign) or articular depression exceeds 2 mm, joint preservation failure rates increase precipitously, shifting the definitive management paradigm to total hip arthroplasty.
• Lesion Topography Dictates Natural History: Necrotic lesion size and location represent the most critical prognostic determinants. Lesions occupying greater than 30% of the femoral head, a modified Kerboul combined necrotic angle greater than 200 degrees, or necrotic bone extending into the lateral weight-bearing dome demonstrate an untreated collapse rate exceeding 80% within 2 to 3 years.
• Core Decompression and Biologic Augmentation: Percutaneous multiple small-diameter drilling (3.0 to 3.2 mm) or single-portal decompression reduces intraosseous venous hypertension, stimulates angiogenesis, and relieves pain. Adding concentrated autologous bone marrow aspirate concentrate (BMAC) containing viable osteoprogenitor cells (yielding greater than 30,000 colony-forming units-fibroblastic) significantly enhances pre-collapse survivorship compared to decompression alone.
• Structural Mechanical Reconstruction: In intermediate pre-collapse or early collapse states without extensive joint loss (ARCO Stage II-C or early III-A), free vascularized fibular grafting (FVFG) provides immediate mechanical structural support to the subchondral plate combined with living osteogenic revascularization, albeit with considerable microsurgical complexity and donor site morbidity.
• Modern Arthroplasty Paradigms: Total hip arthroplasty (THA) is the gold standard for post-collapse osteonecrosis (ARCO Stages III-B and IV). Modern cementless porous-coated titanium stems and acetabular shells coupled with highly cross-linked polyethylene or ceramic bearings demonstrate ten-year implant survivorship exceeding 95%, completely replacing historic cemented constructs and surface replacement procedures.

2. Anatomy and Vascular Supply

Surgical preservation and operative reconstruction of the proximal femur require comprehensive mastery of its extraosseous and intraosseous vascular architecture, mechanical stress corridors, and surrounding neurovascular danger zones.

Arterial Supply to the Femoral Head

The vascular supply of the adult capital femoral epiphysis is predominantly end-arterial and derives from three anatomical vascular networks:

• Medial Femoral Circumflex Artery (MFCA): The deep branch of the MFCA is the principal vascular contributor to the femoral head, supplying greater than 80% of its volume. It courses anterior to the quadratus femoris, runs posterior to the obturator externus tendon, and travels across the posterosuperior aspect of the femoral neck. Prior to penetrating the joint capsule, it branches into 2 to 4 posterosuperior retinacular vessels (lateral epiphyseal arteries). These subsynovial arteries penetrate the head-neck junction and terminal capital epiphysis to supply the weight-bearing anterosuperior quadrant.
• Lateral Femoral Circumflex Artery (LFCA): The ascending and transverse branches of the LFCA contribute to the extracapsular trochanteric arterial ring and supply the inferior femoral neck and anterior trochanteric region via anterior retinacular branches. The LFCA provides minimal direct perfusion to the superior weight-bearing capital epiphysis.
• Artery of the Ligamentum Teres (Foveolar Artery): Arising from the obturator or medial circumflex artery, this vessel enters the fovea capitis to supply a localized non-weight-bearing region surrounding the ligamentum teres insertion (less than 5% to 10% of adult head volume). It is functionally insufficient to maintain head viability following retinacular vessel disruption.

Intraosseous Microvasculature and the Anterosuperior Weight-Bearing Dome

Terminal branches of the lateral epiphyseal arterial system form a dense microvascular capillary network within the subchondral bone directly beneath the articular cartilage of the anterosuperior femoral head. This anatomical region lacks functional intraosseous anastomoses. Because the subchondral bone plate in this location experiences the highest physiologic contact stresses during the stance phase of gait (typically 3 to 5 times body weight), interruptions in perfusion rapidly trigger microvascular thrombosis, marrow ischemia, and focal trabecular death.

Internervous Planes and Surgical Danger Zones

Operative approaches for joint preservation and reconstruction must respect key anatomic corridors:

• Lateral Subtrochanteric Entry Portal (Core Decompression): The drill entry point on the lateral femoral cortex must be placed at or slightly above the level of the lesser trochanter. Positioning the entry portal in the subtrochanteric cortex below the lesser trochanter breaches the dense cortical tension band, creating a high-stress concentration notch that substantially elevates the risk of postoperative subtrochanteric fracture.
• Posterior Corridor (Deep Branch of the MFCA): During posterior approaches or vascularized pedicled bone grafting, the deep branch of the MFCA is vulnerable as it runs immediately superior to the quadratus femoris muscle and deep to the tendon of the obturator externus. Excessive traction or uncoordinated electrocautery at the posterior neck-capsule junction compromises any remaining collateral perfusion.
• Direct Anterior Plane (Smith-Petersen): Utilizes the internervous interval between the tensor fasciae latae (superior gluteal nerve) and the rectus femoris (femoral nerve). The lateral femoral cutaneous nerve (LFCN) crosses the anterior border of the tensor fasciae latae 1 to 2 cm distal to the anterior superior iliac spine (ASIS) and must be identified and protected against traction neuropraxia.

3. Pathogenesis and Etiology

Osteonecrosis results from a multifactorial cascade involving cellular injury, vascular occlusion, intraosseous hypertension, and mechanical failure. Regardless of the initiating insult, the biological pathway converges on terminal microvascular ischemia of the capital epiphysis.

Cellular Ischemia and the Bone Remodeling Paradox

Anoxic osteocyte death occurs within 12 to 48 hours of complete arterial cutoff, followed by hematopoietic cell necrosis within 48 hours and marrow adipocyte necrosis within 5 days. Because the necrotic trabeculae remain structurally intact in their early calcified state, the bone retains immediate mechanical stiffness. Pathologic structural failure ensues only when the host launches a repair response:

• Peripheral Hyperemic Front: Capillary-rich granulation tissue advances from the margins of viable cancellous bone into the dead marrow spaces. Osteoclasts resorb dead necrotic trabeculae in preparation for osteoblastic bone deposition (creeping substitution).
• Resorption-Deposition Mismatch: In the presence of repetitive physiologic cyclic loading, osteoclastic bone resorption outpaces the formation of new, woven, and lamellar bone. The structural scaffold at the junction between living bone and necrotic tissue weakens, leading to microfractures in the unsupported subchondral bone.
• Intraosseous Venous Hypertension: Bone is contained within a rigid cortical compartment. Microvascular thrombosis and adipocyte hypertrophy impair venous drainage, driving resting intraosseous pressures from normal levels (10 to 15 mmHg) to pathological levels (exceeding 30 to 45 mmHg). This pressure gradient causes capillary tamponade and accelerates retrograde tissue ischemia.

Etiologic Classifications

The triggers of osteonecrosis are divided into traumatic and nontraumatic etiologies:

• Trauma: Displaced intracapsular femoral neck fractures (Garden III and IV) shear the posterosuperior retinacular vessels, leading to capital osteonecrosis in 15% to 50% of cases. Posterior hip dislocations compromise vascular flow by stretching or tearing the retinacular vessels, with avascular risk escalating exponentially if closed or open joint reduction is delayed beyond 6 hours.
• Corticosteroid Administration: The most frequent nontraumatic cause. High cumulative doses (greater than 2000 mg prednisone equivalent) or prolonged daily use (greater than 20 mg/day) stimulate mesenchymal stem cell differentiation into adipocytes rather than osteoblasts. Marrow fat cell hypertrophy increases intraosseous volume and pressure, while steroid-induced endothelial dysfunction and hypercoagulability generate microthrombi.
• Excessive Alcohol Consumption: Doses exceeding 400 mL/week induce systemic hyperlipidemia, bone marrow fatty infiltration, and free radical-mediated vascular injury, triggering sinusoidal thrombosis.
• Hemoglobinopathies: In sickle cell anemia (HbSS, HbSC) and thalassemia, sickled red blood cells cause microvascular sludging and sinusoidal thrombosis within the marrow, leading to repeated localized infarctions.
• Thrombophilia and Hypofibrinolysis: Inherited coagulopathies, including Factor V Leiden mutations, prothrombin gene mutation G20210A, protein C and protein S deficiencies, elevated plasminogen activator inhibitor-1 (PAI-1), and antiphospholipid antibodies, predispose to microvascular venous thrombosis.
• Miscellaneous Triggers: Gaucher disease (glucocerebroside marrow accumulation causing venous compression), Caisson disease (decompression sickness with nitrogen bubble embolization), systemic lupus erythematosus, and radiation therapy. Approximately 10% to 20% of cases are idiopathic.

4. Natural History and Risk Factors

Untreated osteonecrosis of the femoral head follows an aggressive, predictable course dictated primarily by the size, location, and stage of the necrotic lesion.

• Epidemiology: The peak incidence occurs between ages 30 and 50, with a male-to-female ratio of approximately 3:1 in alcohol-associated necrosis and 1:1 in corticosteroid-induced disease. Bilateral femoral head involvement occurs in 50% to 80% of nontraumatic patients, mandating magnetic resonance imaging of the contralateral hip even in the absence of symptoms.
• Collapse Progression: Greater than 75% to 85% of symptomatic, untreated hips experience structural collapse within 2 to 3 years of symptom onset. Even asymptomatic hips progress to collapse in over two-thirds of cases when the necrotic lesion involves greater than 30% of the capital volume or extends into the lateral third of the weight-bearing surface.
• The Subchondral Delamination Event: The critical biomechanical turning point occurs when microcracks coalesce into a macroscopic subchondral fracture plane (the crescent sign). Detachment of the articular cartilage from the underlying necrotic bone leads to fluid ingress, rapid subchondral bone collapse, joint incongruity, and secondary degenerative osteoarthritis within 12 to 24 months.

5. Clinical Presentation

Early identification requires clinical vigilance, as physical signs may be subtle or absent during the pre-collapse stages when joint-preserving procedures are most effective.

History

Patients typically describe an insidious onset of dull, throbbing pain localized to the groin (85% of presentations), which may radiate down the anteromedial thigh to the ipsilateral knee or posteriorly into the buttock. Key historical inquiries include:

• Pain Characteristics: Pain is exacerbated by weight-bearing, ambulation, and transitional movements (rising from a seated position). Rest pain and night pain emerge as intraosseous pressure rises or secondary capsulitis develops.
• Acute Pain Exacerbation: A sudden, sharp intensification of chronic groin pain often marks the acute subchondral collapse event (crescent sign formation).
• Mechanical Symptoms: Catching, clicking, locking, or popping sensations indicate articular surface depression, cartilage delamination, or loose chondral fragments.
• Risk Factor Review: Systematic documentation of peak and cumulative corticosteroid exposure, alcohol intake patterns, prior hip dislocations or fractures, autoimmune conditions, and personal or family histories of deep vein thrombosis or pulmonary embolism.

Physical Exam

In early pre-collapse stages (ARCO Stage I and II), the physical examination may be normal or demonstrate only mild end-range discomfort. In progressive and post-collapse disease, examination findings become prominent:

• Gait Analysis: An antalgic gait pattern is typical. With progressive collapse and articular destruction, abductor weakness produces a positive Trendelenburg sign and lurch.
• Range of Motion Restriction: Passive internal rotation in flexion is the earliest and most consistently restricted motion plane. As collapse advances, abduction and flexion (often limited to less than 90 degrees) become progressively blocked.
• Log Roll Maneuver: Passive internal and external rotation of the lower extremity with the hip in full extension tests the articular surface and synovium. Elicitation of groin pain indicates active hip joint pathology.
• Flexion, Adduction, Internal Rotation (FADIR) Test: The hip is flexed to 90 degrees, adducted, and internally rotated. Pain reproduction reflects anterior labral and subchondral mechanical irritation.
• Flexion, Abduction, External Rotation (FABER / Patrick) Test: The ipsilateral ankle is placed over the contralateral knee, and gentle downward pressure is applied to the knee. Anterolateral groin discomfort confirms hip capsular and articular irritation.
• Resisted Straight Leg Raise (Stinchfield Test): The patient actively elevates the extended leg against resistance applied at 30 degrees of hip flexion. Deep groin pain is provoked by the large joint reaction force across the anterosuperior femoral head.

6. Imaging and Diagnostic Studies

Diagnostic imaging must establish both the presence of osteonecrosis and precisely delineate the lesion stage, volume, and mechanical collapse status to guide surgical selection.

Plain Radiography

The standard radiographic evaluation consists of an anteroposterior (AP) pelvis, dedicated AP view of the symptomatic hip, and a 45-degree Dunn or cross-table frog-leg lateral view. The frog-leg lateral projection is essential because it visualizes the anterosuperior capital margin in profile, where early subchondral fractures first appear.

• Pre-Collapse Findings (Stage I and II): Radiographs are normal in Stage I. Stage II is characterized by mottled trabecular osteopenia, patchy cystic radiolucencies, and sclerotic repair margins. The spherical contour of the femoral head remains completely preserved, and joint space width is normal.
• The Crescent Sign (Stage III): A linear subchondral radiolucent line running parallel to the subchondral articular cortex. This represents structural cleavage through necrotic trabeculae and marks the definitive boundary between pre-collapse and collapse phases.
• Post-Collapse Deformity (Stage IV and V): Articular flattening, cortical step-off (measured in millimeters of depression), loss of head sphericity, and secondary acetabular cartilage loss with joint space narrowing and marginal osteophytes.

Magnetic Resonance Imaging (MRI)

MRI is the diagnostic reference standard, with sensitivity and specificity exceeding 99%. It detects osteonecrosis months before plain radiographic alterations become visible.

• T1-Weighted Sequences: A continuous, sharp, low-signal intensity serpentine band (the demarcation line) separating the anterosuperior necrotic bone wedge from normal vascularized cancellous bone in the femoral neck.
• T2-Weighted / STIR Sequences: Demonstrates the pathognomonic double-line sign in up to 80% of hips. This feature consists of an outer low-intensity band (representing sclerotic, hyperdense bone) bordering an inner high-signal intensity line (representing hyperemic, vascularized granulation tissue).
• Bone Marrow Edema (BME): Diffuse high-signal intensity on T2/STIR extending into the femoral neck and intertrochanteric line. Extensive BME correlates strongly with acute pain, intraosseous hypertension, and impending mechanical collapse.
• Modified Kerboul Combined Necrotic Angle: Calculated by summing the arc of the necrotic segment on mid-coronal and mid-sagittal MRI images (or AP and frog-leg lateral radiographs). Lesions are stratified into Grade 1 or Small (combined angle less than 160 degrees, low collapse risk), Grade 2 or Medium (combined angle 160 to 200 degrees, intermediate collapse risk), and Grade 3 or Large (combined angle greater than 200 degrees, high collapse risk exceeding 80%).

Computed Tomography (CT)

Thin-slice multidetector CT with 3D reconstructed reformations is the most sensitive imaging modality for detecting occult subchondral cortical fractures when radiographs are inconclusive. CT precisely measures the depth of articular step-off (under 2 mm vs. greater than 2 mm) and identifies intra-articular loose bodies.

7. Classification

Staging systems classify osteonecrosis to predict the risk of collapse and dictate the threshold between joint preservation and arthroplasty. The two most widely used modern classifications are the University of Pennsylvania (Steinberg) staging system and the Association Research Circulation Osseous (ARCO) classification (revised 2019).

8. Treatment

The definitive management algorithm is structured around a central clinical question: is the hip in a pre-collapse state (ARCO Stage I or II) or has articular collapse occurred (ARCO Stage III or IV)?

Nonoperative Modalities

Nonoperative therapies have poor efficacy when used as definitive single-modality treatments for weight-bearing osteonecrotic lesions, but serve as supportive adjuncts during pre-procedural optimization or rehabilitation:

• Protected Weight-Bearing: Unloading with crutches or a walker reduces mechanical contact stress during acute marrow edema episodes. However, protected weight-bearing alone fails to alter the natural progression to collapse in over 80% of hips with moderate-to-large lesions.
• Bisphosphonates: Nitrogen-containing bisphosphonates (alendronate, zoledronic acid) inhibit osteoclastic bone resorption at the repair front, theoretically delaying trabecular structural failure. While short-term studies demonstrated transient pain reduction, randomized controlled trials and meta-analyses show that bisphosphonates do not prevent collapse or reduce ultimate conversion to total hip arthroplasty.
• Vasoactive and Lipid-Lowering Agents: Statins (atorvastatin) may counter corticosteroid-induced marrow adipogenesis and downregulate lipocyte hypertrophy. Iloprost (a prostacyclin analogue) induces precapillary vasodilation, decreases capillary permeability, and reduces intraosseous marrow edema. Anticoagulants (enoxaparin) show benefit in patients with verified primary thrombophilias.
• Biophysical Stimulation: Extracorporeal shock wave therapy (ESWT) and pulsed electromagnetic fields (PEMF) stimulate angiogenic growth factors (VEGF, basic FGF, BMP-2) and induce local neovascularization. ESWT has shown clinical utility as an adjunct in small, pre-collapse lesions (ARCO Stage I and II-A).

Operative Joint Preservation

Joint-preserving procedures aim to decompress the rigid femoral head compartment, re-establish local vascular perfusion, provide structural support to the subchondral shell, and stimulate bone regeneration before irreversible articular collapse occurs.

• Core Decompression (CD): Percutaneous multiple small-diameter drillings (3.0 to 3.2 mm) or single 8 to 10 mm trephining under biplanar fluoroscopy into the necrotic lesion, terminating 5 mm short of the subchondral bone plate. Decompresses intraosseous venous hypertension, disrupts sclerotic repair margins, and creates vascular channels while preserving 70% more torsional and compressive neck strength than large-diameter coring. Indicated for pre-collapse ARCO Stage I and II lesions (Kerboul angle less than 200 degrees), yielding 70% to 85% five-year joint preservation.
• Core Decompression Augmented with Cell Therapy (BMAC): Autologous bone marrow harvested from the iliac crest is concentrated via centrifugation to isolate mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs) and injected percutaneously into the necrotic cavity. Delivering concentrated cells exceeding 30,000 CFU-F significantly improves clinical survivorship and reduces collapse rates compared to core decompression alone in ARCO Stage I and II disease.
• Non-Vascularized Bone Grafting (Phemister / Trapdoor Techniques): Debridement of necrotic bone through a cortical femoral neck window or articular trapdoor flap, packed with autologous cancellous bone graft, demineralized bone matrix, or synthetic osteoconductive calcium phosphate/sulfate cements. Provides intermediate subchondral structural support with 50% to 75% pre-collapse survivorship, but fails rapidly if chondral delamination is present.
• Free Vascularized Fibular Grafting (FVFG): Docking of a 12 to 15 cm vascularized fibular strut into the subchondral necrotic dome with microvascular anastomosis to the ascending branch of the lateral femoral circumflex artery. Provides immediate mechanical cortical support and living osteogenic revascularization, achieving 80% to 90% pre-collapse survivorship and 60% to 70% in early collapse with depression under 2 mm (ARCO III-A), balanced against prolonged operative times and donor site morbidity.
• Proximal Femoral Osteotomies (Sugioka Rotational / Intertrochanteric): Transtrochanteric rotational or varus/valgus osteotomies reposition the necrotic anterosuperior dome out of the primary weight-bearing contact corridor, replacing it with viable posterior or inferior articular cartilage. Rarely performed due to high nonunion rates, secondary collapse, and anatomical distortions that complicate future total hip arthroplasty.

Arthroplasty

Total hip arthroplasty is the definitive treatment for post-collapse osteonecrosis and failed joint preservation:

• Total Hip Arthroplasty (THA): The gold standard for post-collapse osteonecrosis and failed joint preservation. Modern cementless porous-coated or hydroxyapatite-coated titanium femoral stems achieve predictable osseointegration in metaphyseal and diaphyseal bone distal to the necrotic capital epiphysis. Highly cross-linked polyethylene (HXLPE) liners paired with ceramic or cobalt-chromium heads, or ceramic-on-ceramic (CoC) bearing couples, provide 10-to-15-year implant survivorship exceeding 95% to 98%.
• Hip Resurfacing Arthroplasty (HRA): Historically considered in young males to preserve femoral bone stock, but compromised by persistent necrotic bone beneath the femoral component, component loosening, avascular femoral neck fracture, and adverse local tissue reactions (ALTR) from metal-on-metal wear. Contraindicated if necrotic involvement exceeds 30% to 50% of head volume.
• Hemiarthroplasty: Strictly contraindicated in active patients due to rapid native acetabular cartilage erosion and intractable groin pain requiring early conversion to THA.

Indications and Contraindications

The operative selection threshold is defined by objective geometric and radiographic criteria:

• Indications for Core Decompression ± BMAC: Symptomatic ARCO Stage I or II (Steinberg Stage I or II); verified pre-collapse status on CT and MRI (crescent sign absent, articular step-off 0 mm); necrotic volume under 30% of femoral head; modified Kerboul combined necrotic angle under 200 degrees.
• Indications for Vascularized Bone Grafting (FVFG): Physiologically young patients (age under 50 years); large pre-collapse lesions (ARCO Stage II-C, Kerboul angle greater than 200 degrees); or early subchondral collapse (ARCO Stage III-A) with focal depression under 2 mm and preserved acetabular cartilage.
• Contraindications to Joint Preservation: Articular depression exceeding 2 mm (ARCO Stage III-B); acetabular cartilage wear, joint space narrowing, or secondary osteoarthritis (ARCO Stage IV); capital necrosis involving greater than 50% of the femoral head; or active high-dose corticosteroid therapy and uncontrolled systemic inflammatory disease.

9. Outcome

Data-driven survivorship and functional outcomes stratify according to the mechanical integrity of the femoral head at the time of surgical intervention:

• Core Decompression Alone: In small-to-medium pre-collapse lesions (ARCO Stage I/II-A), five-year joint preservation rates range from 70% to 85%, with substantial improvement in Harris Hip Scores (HHS). When applied to large pre-collapse lesions (greater than 30% volume) or post-collapse hips, survivorship plummets to 25% to 40% at 3 to 5 years.
• Core Decompression with BMAC: Prospective comparative trials demonstrate that adding high-density autologous bone marrow concentrate yields an 80% to 92% five-year survival rate without conversion to THA in pre-collapse hips, demonstrating superior pain reduction and cartilage preservation compared to decompression alone.
• Free Vascularized Fibular Grafting: Long-term follow-up demonstrates 10-year survivorship of 80% to 88% in pre-collapse disease, and 60% to 65% in early collapse with depression under 2 mm. Over 80% of patients achieve satisfactory Harris Hip Scores, but 10% to 15% experience minor or major donor site morbidities.
• Modern Total Hip Arthroplasty: Cementless THA utilizing highly cross-linked polyethylene or ceramic bearings achieves 10-to-15-year implant survivorship rates of 95% to 98% in osteonecrosis cohorts. Validated patient-reported outcomes (HOOS, WOMAC, HHS) show functional restoration and pain relief comparable to osteoarthritis cohorts of similar age.

10. Complications

Complications in the operative management of osteonecrosis range from technique-specific technical errors during joint preservation to systemic and mechanical complications following arthroplasty.

11. Pearls and Pitfalls

Master surgeons integrate strict technical benchmarks during joint preservation and arthroplasty to avoid catastrophic pitfalls:

• The Lateral Cortex Entry Rule: Never place the starting drill hole for core decompression below the level of the lesser trochanter. Breaching the tensile lateral femoral cortex distal to the trochanter creates a severe stress riser that predisposes the patient to a displaced subtrochanteric fracture during early postoperative mobilization.
• Biplanar Fluoroscopic Verification: Continuously oscillate between true AP and cross-table lateral fluoroscopic views during decompression. A drill bit that appears centrally positioned on an AP image may be dangerously anterior or posterior on the lateral projection, risking joint penetration or missing the necrotic wedge entirely.
• Small-Drill Multiple Coring Over Single Trephine: Utilize multiple passes with a 3.0 to 3.2 mm drill rather than an 8 to 10 mm single trephine whenever possible. Multiple drill tracks decompress separate necrotic quadrants, distribute stress evenly, and preserve 70% more torsional and compressive neck strength.
• Biologic Processing Rigor: When delivering BMAC, harvest at least 60 mL of marrow from the posterior iliac crest (which contains higher progenitor cell concentrations than the anterior crest). Avoid diluting aspirate with peripheral blood by limiting aspiration to 5 mL aliquots per puncture site, and ensure the concentrated cellular volume reaches the target threshold of at least 30,000 CFU-F.
• The Articular Cartilage Trap: In early collapse (crescent sign), the articular cartilage may appear macroscopically normal despite underlying necrotic cavitation. Do not attempt core decompression in the presence of a subchondral fracture; joint decompression cannot reconstitute collapsed trabecular architecture.

12. Controversy

Several clinical dilemmas remain active subjects of debate in orthopaedic reconstructive surgery:

• Management of Asymptomatic Pre-Collapse Lesions: Whether to intervene with core decompression in an asymptomatic patient with an incidentally discovered MRI lesion remains controversial. While small medial lesions (Kerboul angle under 160 degrees) can be safely observed with serial imaging, consensus favors proactive decompression with cell therapy for moderate-to-large lateral lesions (Kerboul angle greater than 200 degrees) due to an untreated collapse rate exceeding 80%.
• Cell Therapy: BMAC vs. Cultured Osteoprogenitors: While autologous BMAC has demonstrated consistent clinical benefits as a point-of-care biologic, double-blind randomized clinical trials evaluating ex-vivo expanded, cultured autologous osteoblastic or mesenchymal cells have shown no statistically significant reduction in collapse or THA conversion rates compared to core decompression alone, calling into question the cost and regulatory burden of cultured cell expansion.
• Structural Metal Implants: Porous tantalum trabecular metal rods were introduced to provide mechanical subchondral support while facilitating bone ingrowth. Long-term registries revealed unacceptably high mechanical failure rates and demonstrated that extracting well-fixed tantalum rods during subsequent conversion to THA caused massive proximal femoral bone loss. Porous metal rods have largely been abandoned.
• Optimal Bearing Couple for Young Osteonecrosis Patients: While ceramic-on-ceramic (CoC) eliminates polyethylene wear and osteolysis, it carries small risks of squeaking and catastrophic ceramic liner fracture. Modern ceramic-on-highly crosslinked polyethylene (CoP) demonstrates comparably low wear rates with forgiving mechanics, leading many surgeons to prefer CoP even in patients under 40 years of age.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Jayankura M, Thomas T, Seefried L et al. Does Adjunction of Autologous Osteoblastic Cells Improve the Results of Core Decompression in Early-stage Femoral Head Osteonecrosis? A Double-blind, Randomized Trial. Clin Orthop Relat Res. 2023. doi:10.1097/CORR.0000000000002610 [Level I: Randomized Controlled Trial]
• Parikh RR, Mirzaei A, Butler ME et al. Diagnosis and Treatment of Nontraumatic Osteonecrosis of the Femoral Head: A Systematic Review and Meta-Analyses for the ARCO Clinical Practice Guideline Development Workgroup. Med Sci (Basel). 2026. doi:10.3390/medsci14010107 [Level I: Systematic Review / Meta-Analysis]
• Matthew B. Murphy, Kathryn Moncivais, Arnold I. Caplan. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Experimental & Molecular Medicine. 2013. doi:10.1038/emm.2013.94 [Level IV (Prognostic / Case Series): Seminal Conceptual / Observational Study]
• Joaquín Moya-Angeler. Current concepts on osteonecrosis of the femoral head. World Journal of Orthopedics. 2015. doi:10.5312/wjo.v6.i8.590 [Level IV (Prognostic / Case Series): Seminal Conceptual / Observational Study]
• Ching‐Jen Wang. Extracorporeal shockwave therapy in musculoskeletal disorders. Journal of Orthopaedic Surgery and Research. 2012. doi:10.1186/1749-799x-7-11 [Level IV (Prognostic / Case Series): Seminal Conceptual / Observational Study]

15. Master Class Pro-Tip

When executing joint preservation for pre-collapse osteonecrosis, success depends entirely on biological and mechanical containment. Under dual fluoroscopic control, establish your lateral cortical drill entry at or above the level of the lesser trochanter to prevent creating a subtrochanteric stress riser. Advance multiple 3.2 mm drill pins into the anterior and superior weight-bearing necrotic sector, halting precisely 5 mm short of the subchondral bone plate. Breaching the subchondral shell or articular cartilage vents your biologic graft into the joint and accelerates chondrolysis. If utilizing bone marrow aspirate concentrate, harvest in 5 mL aliquots from multiple sites along the posterior iliac crest to optimize progenitor cell yields, centrifuge to achieve a cell concentration exceeding 30,000 CFU-F, and seal the delivery tract with a collagen-calcium plug. However, once the subchondral crescent sign appears or articular depression exceeds 2 mm, abort joint preservation; immediate transition to cementless total hip arthroplasty with high-offset geometry and a modern cross-linked bearing delivers definitive, predictable long-term survivorship.

Master Class Surgical Pearl: Joint Preservation in Femoral Head Osteonecrosis